Shares of MedPlus Health Services were trading almost 1% lower after its subsidiary received drug licence suspension orders from the Drug Control Administration.

In its regulatory filing, the company said that it had received an order from the assistant director and drug sales licensing authority of the Drug Control Administration, Mahabubnagar TS, for the suspension of the licence for six days for the store at Shankarpally Jadcherla.

The company has also received another order from the assistant director of the Drugs Control Administration, Ranga Reddy TS, for a seven-day licence suspension for a store at HayathNagar.

These suspension orders were issued on 4 January.

The subsidiary of the company has also received a drug licence suspension from the assistant director of Drugs Control Administration, Ranga Reddy, for the suspension of a drug licence for three days for sales premises at Mangalpally village Bongloor and a suspension of a drug licence for five days for sales premises at Padmavathi Colony Hasthinapuram.

The filing added that the licence suspension orders were issued for violating various conditions of licences issued to provisions of Section 65 / Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.

In December, the company’s subsidiary received orders from the assistant director of the drug sales licensing authority and drug control authorities from various locations.

At 12:25 pm, the shares of MedPlus Health Services were trading 0.35% lower at Rs 747.90 on NSE.